Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine
Clinical trial NCT05526183 · UNKNOWN
Trial details
- NCT number
- NCT05526183
- Sponsor
- Ankara City Hospital Bilkent
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2022-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.